Medexus Pharmaceuticals Inc T.MDP

Short vol low...

[Rockafellow]

Should start new run sooner than later... 
... ... 
... ... 
I don't think listing on Nasdaq will b that beneficial because of the low float.
Any thoughts???

[oceaneleven]

Low float and positive news can send this flying with a Nasdaq listing.. we had some insider buying first two weeks of this month but has stopped so me thinks announcement coming.....

[GoldenArm]

Speculation is the game here. I don't know what will happen once they are listed Looking at the facts, April listing would be beneficial because they can announce Q4 results after. The big news will be if treosulfan is approved for sale in US by FDA which I believe it will. As for the company itself: YoY nearly doubled revenue, lots of cash on hand ,  reduced Admin and selling costs

[Paparico1]

"The key point of listing on the Nasdaq was to get exposure into the market that derive most of their revenue. I would assume this is so the price per share would go up so if need they could do a PP for more acquistions of distribution agreements." MDP has no US analyst, so when they get on the Nasdaq will not be an easy start. Everybody thinks it's a given but it isn't. The

[oceaneleven]

https://www.sagehealthcare.com/single-post/the-sage-group-announces-transaction-between-medac-gmbh-and-medexus-pharma-for-treosulfan-in-the-usa